First Trust Nasdaq Pharmaceuticals ETF Holdings
FTXH was created on 2016-09-20 by First Trust. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 29.34m in AUM and 51 holdings. FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.
Last Updated: 4 days, 13 hours ago
Last reported holdings - First Trust Nasdaq Pharmaceuticals ETF
| Ticker | Name | Est. Value |
|---|
Recent Changes - First Trust Nasdaq Pharmaceuticals ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2026-03-22 |
TARS
|
Tarsus Pharmaceuticals Inc Ordinary Shares | 2,012 |
| 2026-03-22 |
PBH
|
Prestige Consumer Healthcare Inc | -1,835 |
| 2026-03-22 |
TWST
|
Twist Bioscience Corp | 3,238 |
| 2026-03-22 |
TXG
|
10x Genomics Inc Ordinary Shares - Class A | 6,591 |
| 2026-03-22 |
ROIV
|
Roivant Sciences Ltd Ordinary Shares | 5,250 |
| 2026-03-22 |
CORT
|
Corcept Therapeutics Inc | -1,683 |
| 2026-03-22 |
SYRE
|
Spyre Therapeutics Inc | 3,533 |
| 2026-03-22 |
MDGL
|
Madrigal Pharmaceuticals Inc | -269 |
| 2026-03-22 |
ARQT
|
Arcutis Biotherapeutics Inc Ordinary Shares | 5,633 |
| 2026-03-22 |
TVTX
|
Travere Therapeutics Inc Ordinary Shares | 5,100 |
| 2026-03-22 |
RYTM
|
Rhythm Pharmaceuticals Inc | -1,138 |
| 2026-03-22 |
INSM
|
Insmed Inc | -864 |
| 2026-03-22 |
ADMA
|
ADMA Biologics Inc | -6,798 |
| 2026-03-22 |
MRNA
|
Moderna Inc | 2,836 |
| 2026-03-22 |
BBIO
|
BridgeBio Pharma Inc | -2,265 |
| 2026-03-22 |
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | 1,663 |
| 2026-03-22 |
RCUS
|
Arcus Biosciences Inc | 7,459 |
| 2026-03-22 |
PRGO
|
Perrigo Co PLC | -6,406 |
| 2026-03-22 |
NAMS
|
NewAmsterdam Pharma Co NV | -4,879 |
| 2026-03-22 |
TEM
|
Tempus AI Inc Class A common stock | -1,547 |
| 2025-09-21 |
OGN
|
Organon & Co Ordinary Shares | -27,775 |
| 2025-09-21 |
SUPN
|
Supernus Pharmaceuticals Inc | 1,689 |
| 2025-09-21 |
EXAS
|
Exact Sciences Corp | -1,665 |
| 2025-09-21 |
SRPT
|
Sarepta Therapeutics Inc | -740 |
| 2025-09-21 |
RYTM
|
Rhythm Pharmaceuticals Inc | 739 |
| 2025-09-21 |
BBIO
|
BridgeBio Pharma Inc | 1,472 |
| 2025-09-21 |
ARWR
|
Arrowhead Pharmaceuticals Inc | 3,459 |
| 2025-09-21 |
TEM
|
Tempus AI Inc Class A common stock | 1,005 |
| 2025-09-21 |
AXSM
|
Axsome Therapeutics Inc | -619 |
| 2025-09-21 |
AKRO
|
Akero Therapeutics Inc | -1,607 |
| 2025-09-21 |
VCYT
|
Veracyte Inc | -2,271 |
| 2025-09-21 |
VCEL
|
Vericel Corp | -1,539 |
| 2025-09-21 |
NAMS
|
NewAmsterdam Pharma Co NV | 3,168 |
| 2025-09-21 |
PTGX
|
Protagonist Therapeutics Inc | 1,290 |
| 2025-09-21 |
MIRM
|
Mirum Pharmaceuticals Inc | 1,032 |
| 2025-09-21 |
SRRK
|
Scholar Rock Holding Corp | -2,034 |
| 2025-09-21 |
IONS
|
Ionis Pharmaceuticals Inc | 1,787 |
| 2025-09-21 |
LGND
|
Ligand Pharmaceuticals Inc | 471 |
| 2025-07-16 |
BPMC
|
Blueprint Medicines Corp | -810 |
| 2025-06-25 |
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | -1,970 |
| 2025-03-23 |
MYGN
|
Myriad Genetics Inc | -2,860 |
| 2025-03-23 |
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | 1,354 |
| 2025-03-23 |
IONS
|
Ionis Pharmaceuticals Inc | -1,699 |
| 2025-03-23 |
VKTX
|
Viking Therapeutics Inc | -1,264 |
| 2025-03-23 |
TWST
|
Twist Bioscience Corp | -1,874 |
| 2025-03-23 |
PTGX
|
Protagonist Therapeutics Inc | -2,653 |
| 2025-03-23 |
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | -1,676 |
| 2025-03-23 |
CPRX
|
Catalyst Pharmaceuticals Inc | 4,650 |
| 2025-03-23 |
GH
|
Guardant Health Inc | 1,838 |
| 2025-03-23 |
MDGL
|
Madrigal Pharmaceuticals Inc | 229 |
| 2025-03-23 |
ILMN
|
Illumina Inc | 2,967 |
| 2025-03-23 |
ITCI
|
Intra-Cellular Therapies Inc | -1,110 |
| 2025-03-23 |
PTCT
|
PTC Therapeutics Inc | 1,415 |
| 2025-03-23 |
ACLX
|
Arcellx Inc | -1,179 |
| 2025-03-23 |
AXSM
|
Axsome Therapeutics Inc | 613 |
| 2025-03-23 |
VCYT
|
Veracyte Inc | 2,249 |
| 2025-03-23 |
SRRK
|
Scholar Rock Holding Corp | 2,014 |
| 2025-03-23 |
RNA
|
Avidity Biosciences Inc Ordinary Shares | -1,842 |
| 2025-03-23 |
AKRO
|
Akero Therapeutics Inc | 1,592 |
| 2025-03-23 |
ROIV
|
Roivant Sciences Ltd Ordinary Shares | -6,626 |
| 2024-09-22 |
RYTM
|
Rhythm Pharmaceuticals Inc | -1,915 |
| 2024-09-22 |
PTGX
|
Protagonist Therapeutics Inc | 2,899 |
| 2024-09-22 |
NUVL
|
Nuvalent Inc Class A | -988 |
| 2024-09-22 |
ILMN
|
Illumina Inc | -796 |
| 2024-09-22 |
VCEL
|
Vericel Corp | 1,720 |
| 2024-09-22 |
RARE
|
Ultragenyx Pharmaceutical Inc | -1,608 |
| 2024-09-22 |
INSM
|
Insmed Inc | 1,162 |
| 2024-09-22 |
RNA
|
Avidity Biosciences Inc Ordinary Shares | 2,020 |
| 2024-09-22 |
MYGN
|
Myriad Genetics Inc | 3,137 |
| 2024-09-22 |
TWST
|
Twist Bioscience Corp | 2,055 |
| 2024-09-22 |
AMRX
|
Amneal Pharmaceuticals Inc Ordinary Shares - Class A | 10,261 |
| 2024-09-22 |
ADMA
|
ADMA Biologics Inc | 5,134 |
| 2024-09-22 |
BEAM
|
Beam Therapeutics Inc | -2,105 |
| 2024-09-22 |
ARVN
|
Arvinas Inc | -1,808 |
| 2024-09-22 |
CORT
|
Corcept Therapeutics Inc | 2,517 |
| 2024-09-22 |
MRUS
|
Merus NV | -1,715 |
| 2024-09-22 |
IDYA
|
IDEAYA Biosciences Inc | -1,860 |
| 2024-09-22 |
MLTX
|
MoonLake Immunotherapeutics Class A | -1,724 |
| 2024-09-22 |
CRSP
|
CRISPR Therapeutics AG | -987 |
| 2024-09-22 |
ALNY
|
Alnylam Pharmaceuticals Inc | 423 |
| 2024-07-04 |
GRAL
|
GRAIL Inc | -165 |
| 2024-06-25 |
GRAL
|
GRAIL Inc | 166 |
| 2024-03-17 |
VKTX
|
Viking Therapeutics Inc | 1,345 |
| 2024-03-17 |
RYTM
|
Rhythm Pharmaceuticals Inc | 2,387 |
| 2024-03-17 |
CTLT
|
Catalent Inc | -3,449 |
| 2024-03-17 |
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | 2,427 |
| 2024-03-17 |
ACLX
|
Arcellx Inc | 1,885 |
| 2024-03-17 |
NUVL
|
Nuvalent Inc Class A | 1,232 |
| 2024-03-17 |
CRSP
|
CRISPR Therapeutics AG | 1,231 |
| 2024-03-17 |
ARVN
|
Arvinas Inc | 2,254 |
| 2024-03-17 |
IDYA
|
IDEAYA Biosciences Inc | 2,319 |
| 2024-03-17 |
GH
|
Guardant Health Inc | -2,610 |
| 2024-03-17 |
PACB
|
Pacific Biosciences of California Inc | -9,042 |
| 2024-03-17 |
RARE
|
Ultragenyx Pharmaceutical Inc | 2,004 |
| 2024-03-17 |
ALNY
|
Alnylam Pharmaceuticals Inc | -516 |
| 2024-03-17 |
AXSM
|
Axsome Therapeutics Inc | -1,262 |
| 2024-03-17 |
BPMC
|
Blueprint Medicines Corp | 1,108 |
| 2024-03-17 |
BEAM
|
Beam Therapeutics Inc | 2,624 |
| 2024-03-17 |
MORF
|
Morphic Holding Inc | -1,852 |
| 2024-03-17 |
AMPH
|
Amphastar Pharmaceuticals Inc | -1,913 |
| 2024-03-17 |
FOLD
|
Amicus Therapeutics Inc | -7,956 |
| 2024-03-17 |
PCVX
|
Vaxcyte Inc Ordinary Shares | -1,964 |
| 2024-03-17 |
RVMD
|
Revolution Medicines Inc Ordinary Shares | -3,002 |
| 2024-03-17 |
TGTX
|
TG Therapeutics Inc | 6,018 |
| 2024-03-17 |
AKRO
|
Akero Therapeutics Inc | -2,055 |
| 2024-03-17 |
MRUS
|
Merus NV | 2,138 |
| 2024-03-17 |
MRNA
|
Moderna Inc | -902 |
| 2024-01-31 |
IMGN
|
Immunogen Inc | -6,369 |
| 2023-11-16 |
MURA
|
Mural Oncology PLC | 400 |
| 2023-09-14 |
RVMD
|
Revolution Medicines Inc Ordinary Shares | 3,377 |
| 2023-09-14 |
ILMN
|
Illumina Inc | 694 |
| 2023-09-14 |
MORF
|
Morphic Holding Inc | 2,083 |
| 2023-09-14 |
KRTX
|
Karuna Therapeutics Inc | -574 |
| 2023-09-14 |
HRMY
|
Harmony Biosciences Holdings Inc Ordinary Shares | -2,598 |
| 2023-09-14 |
PTCT
|
PTC Therapeutics Inc | -2,620 |
| 2023-09-14 |
PRTA
|
Prothena Corp PLC | -2,052 |
| 2023-09-14 |
AMPH
|
Amphastar Pharmaceuticals Inc | 2,152 |
| 2023-09-14 |
VIR
|
Vir Biotechnology Inc | -5,017 |
| 2023-09-14 |
GH
|
Guardant Health Inc | 2,935 |
| 2023-09-14 |
KRYS
|
Krystal Biotech Inc | 922 |
| 2023-09-14 |
MLTX
|
MoonLake Immunotherapeutics Class A | 1,993 |
| 2023-09-14 |
NVCR
|
NovoCure Ltd | -1,486 |
| 2023-09-14 |
PACB
|
Pacific Biosciences of California Inc | 10,169 |
| 2023-09-14 |
IMGN
|
Immunogen Inc | 7,242 |
| 2023-09-14 |
ITCI
|
Intra-Cellular Therapies Inc | 2,066 |
| 2023-09-14 |
AKRO
|
Akero Therapeutics Inc | 2,311 |
| 2023-08-02 |
SYNH
|
Syneos Health Inc Class A | -5,982 |
| 2023-07-06 |
ISEE
|
IVERIC bio Inc | -6,009 |
| 2023-06-15 |
RXDX
|
Prometheus Biosciences Inc | -1,228 |
| 2023-05-30 |
SGEN
|
Seagen Inc Ordinary Shares | -868 |
| 2023-03-21 |
PRTA
|
Prothena Corp PLC | 3,029 |
| 2023-03-21 |
EBS
|
Emergent BioSolutions Inc | -51,947 |
| 2023-03-21 |
BPMC
|
Blueprint Medicines Corp | -13,371 |
| 2023-03-21 |
PCRX
|
Pacira BioSciences Inc | -13,244 |
| 2023-03-21 |
CORT
|
Corcept Therapeutics Inc | -25,276 |
| 2023-03-21 |
KRTX
|
Karuna Therapeutics Inc | 847 |
| 2023-03-21 |
NVCR
|
NovoCure Ltd | 2,194 |
| 2023-03-21 |
RXDX
|
Prometheus Biosciences Inc | 1,380 |
| 2023-03-21 |
IRWD
|
Ironwood Pharmaceuticals Inc Class A | -122,961 |
| 2023-03-21 |
AXSM
|
Axsome Therapeutics Inc | 2,477 |
| 2023-03-21 |
ALNY
|
Alnylam Pharmaceuticals Inc | 882 |
| 2023-03-21 |
HALO
|
Halozyme Therapeutics Inc | 4,851 |
| 2023-03-21 |
VIR
|
Vir Biotechnology Inc | 7,408 |
| 2023-03-21 |
SRPT
|
Sarepta Therapeutics Inc | 1,383 |
| 2023-03-21 |
ROIV
|
Roivant Sciences Ltd Ordinary Shares | 20,878 |
| 2023-03-21 |
EXAS
|
Exact Sciences Corp | 2,710 |
| 2023-03-21 |
SYNH
|
Syneos Health Inc Class A | 8,956 |
| 2023-03-21 |
EXEL
|
Exelixis Inc | 15,809 |
| 2023-03-21 |
ISEE
|
IVERIC bio Inc | 8,128 |
| 2023-03-21 |
MEDP
|
Medpace Holdings Inc | 1,923 |
| 2023-03-21 |
ACAD
|
ACADIA Pharmaceuticals Inc | 8,164 |
| 2023-03-21 |
CRL
|
Charles River Laboratories International Inc | 2,521 |
| 2023-03-21 |
NBIX
|
Neurocrine Biosciences Inc | 1,952 |
| 2023-03-21 |
PTCT
|
PTC Therapeutics Inc | 3,868 |
| 2023-03-21 |
MRNA
|
Moderna Inc | 8,754 |
| 2023-03-21 |
REGN
|
Regeneron Pharmaceuticals Inc | 1,598 |
| 2023-03-21 |
FOLD
|
Amicus Therapeutics Inc | 12,805 |
| 2023-03-21 |
HRMY
|
Harmony Biosciences Holdings Inc Ordinary Shares | 3,836 |
| 2023-03-21 |
BIIB
|
Biogen Inc | 4,022 |
| 2023-03-21 |
INCY
|
Incyte Corp | 10,091 |
| 2023-03-21 |
PCVX
|
Vaxcyte Inc Ordinary Shares | 4,123 |
| 2023-02-27 |
HZNP
|
Horizon Therapeutics PLC | -7,444 |
| 2023-01-17 |
IFC 2.875 07.31.23 GMTN
|
Vertex Pharmaceuticals Inc | -3,343 |
| 2023-01-17 |
VRTX
|
Vertex Pharmaceuticals Inc | 3,343 |
| 2023-01-13 |
IFC 2.875 07.31.23 GMTN
|
Vertex Pharmaceuticals Inc | 3,343 |
| 2023-01-13 |
VRTX
|
Vertex Pharmaceuticals Inc | -3,343 |
| 2022-08-23 |
ENDP
|
Endo International PLC | -1.4 million |
| 2022-08-19 |
BMY
|
Bristol-Myers Squibb Co | -1,418 |
| 2022-08-19 |
JNJ
|
Johnson & Johnson | -596 |
| 2022-08-19 |
ELAN
|
Elanco Animal Health Inc | -1,013 |
| 2022-08-19 |
BPMC
|
Blueprint Medicines Corp | -437 |
| 2022-08-18 |
MRK
|
Merck & Co Inc | -3,486 |
| 2022-08-18 |
PFE
|
Pfizer Inc | -6,054 |
| 2022-08-18 |
PBH
|
Prestige Consumer Healthcare Inc | -4,980 |
| 2022-08-18 |
VRTX
|
Vertex Pharmaceuticals Inc | -1,182 |
| 2022-08-18 |
CORT
|
Corcept Therapeutics Inc | -6,924 |
| 2022-08-18 |
LLY
|
Eli Lilly and Co | -786 |
| 2022-08-18 |
VTRS
|
Viatris Inc | -26,160 |
| 2022-08-18 |
JNJ
|
Johnson & Johnson | -3,576 |
| 2022-08-18 |
BPMC
|
Blueprint Medicines Corp | -2,622 |
| 2022-08-18 |
ALKS
|
Alkermes PLC | -4,824 |
| 2022-08-18 |
ENDP
|
Endo International PLC | -272,892 |
| 2022-08-18 |
BMY
|
Bristol-Myers Squibb Co | -8,508 |
| 2022-08-18 |
ELAN
|
Elanco Animal Health Inc | -6,078 |
| 2022-08-08 |
BMY
|
Bristol-Myers Squibb Co | 4,254 |
| 2022-08-08 |
PFE
|
Pfizer Inc | 3,027 |
| 2022-08-08 |
OGN
|
Organon & Co Ordinary Shares | 4,227 |
| 2022-08-08 |
ENDP
|
Endo International PLC | 136,446 |
| 2022-08-08 |
LLY
|
Eli Lilly and Co | 393 |
| 2022-08-08 |
JNJ
|
Johnson & Johnson | 1,788 |
| 2022-08-08 |
BPMC
|
Blueprint Medicines Corp | 1,311 |
| 2022-08-08 |
IONS
|
Ionis Pharmaceuticals Inc | 1,971 |
| 2022-08-08 |
UTHR
|
United Therapeutics Corp | 399 |
| 2022-08-08 |
GILD
|
Gilead Sciences Inc | 4,950 |
| 2022-08-08 |
EBS
|
Emergent BioSolutions Inc | 2,184 |
| 2022-08-08 |
VRTX
|
Vertex Pharmaceuticals Inc | 591 |
| 2022-08-08 |
AMGN
|
Amgen Inc | 1,104 |
| 2022-07-27 |
JNJ
|
Johnson & Johnson | 596 |
| 2022-07-27 |
IRWD
|
Ironwood Pharmaceuticals Inc Class A | 4,747 |
| 2022-07-27 |
PBH
|
Prestige Consumer Healthcare Inc | 830 |